Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$900M |
| 2 |
Cisco
CSCO
|
+$204M |
| 3 |
Amazon
AMZN
|
+$152M |
| 4 |
Johnson & Johnson
JNJ
|
+$150M |
| 5 |
Brookfield Infrastructure
BIPC
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$430M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$305M |
| 3 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$299M |
| 4 |
Merck
MRK
|
+$291M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTX
2826
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.64M | ﹤0.01% |
487,201
+100,939
| +26% | +$260K |
|
2827
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.63M | ﹤0.01% |
3
+1
| +50% | +$534K |
|
|
CMBM
2828
DELISTED
Cambium Networks
CMBM
| $1.63M | ﹤0.01% |
271,078
-47,668
| -15% | -$234K |
|
|
CUK
2829
DELISTED
Carnival PLC
CUK
| $1.6M | ﹤0.01% |
94,687
-1,673
| -2% | -$21.9K |
|
2830
Ardelyx
ARDX
$1.22B
| $1.59M | ﹤0.01% |
256,956
-11,697
| -4% | -$52.5K |
|
2831
American Well
AMWL
$180M
| $1.59M | ﹤0.01% |
53,458
-41,632
| -44% | -$1.02M |
|
2832
Tandem Diabetes Care
TNDM
$1.34B
| $1.59M | ﹤0.01% |
53,832
-81,177
| -60% | -$1.68M |
|
2833
Espey Mfg & Electronics Corp
ESP
$177M
| $1.59M | ﹤0.01% |
85,032
-1,949
| -2% | -$33.1K |
|
2834
Urban One Class A
UONE
$22.8M
| $1.59M | ﹤0.01% |
39,446
-948
| -2% | -$44.4K |
|
2835
Flanigan's Enterprises
BDL
$77.6M
| $1.58M | ﹤0.01% |
61,585
+974
| +2% | +$26.8K |
|
2836
Emergent Biosolutions
EBS
$373M
| $1.58M | ﹤0.01% |
658,220
-143,383
| -18% | -$337K |
|
2837
Aura Biosciences
AURA
$725M
| $1.58M | ﹤0.01% |
177,718
+66,178
| +59% | +$560K |
|
2838
Frontier Group Holdings
ULCC
$1.55B
| $1.57M | ﹤0.01% |
288,120
-86,752
| -23% | -$379K |
|
2839
Greene County Bancorp
GCBC
$570M
| $1.57M | ﹤0.01% |
55,618
+1,088
| +2% | +$27.3K |
|
|
CBL
2840
CBL Properties
CBL
$1.82B
| $1.57M | ﹤0.01% |
64,296
+10,972
| +21% | +$245K |
|
|
LKFT
2841
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $1.56M | ﹤0.01% |
38,432
+31,325
| +441% | +$1.15M |
|
2842
GDS Holdings
GDS
$6.56B
| $1.54M | ﹤0.01% |
169,250
-4,716
| -3% | -$47.7K |
|
|
NTCO
2843
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $1.54M | ﹤0.01% |
225,220
-10,178
| -4% | -$61.2K |
|
|
PINE
2844
Alpine Income Property Trust
PINE
$333M
| $1.54M | ﹤0.01% |
91,052
+13,816
| +18% | +$225K |
|
2845
HDFC Bank
HDB
$123B
| $1.53M | ﹤0.01% |
+45,668
| New | +$1.38M |
|
2846
Coca-Cola Europacific Partners
CCEP
$48.3B
| $1.53M | ﹤0.01% |
22,943
+93
| +0.4% | +$5.69K |
|
2847
CEMIG Preferred Shares
CIG
$6.26B
| $1.53M | ﹤0.01% |
856,499
-23,728
| -3% | -$43K |
|
2848
Harrow
HROW
$1.45B
| $1.52M | ﹤0.01% |
135,440
-179,700
| -57% | -$2.13M |
|
2849
Theravance Biopharma
TBPH
$874M
| $1.5M | ﹤0.01% |
133,184
+61,564
| +86% | +$620K |
|
2850
Outdoor Holding Co
POWW
$249M
| $1.48M | ﹤0.01% |
705,986
+475,450
| +206% | +$1.08M |
|
Similar funds
Dimensional Fund Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Dimensional Fund Advisors held 3,516 positions worth $342B, up 12% from $305B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 4.3%. Dimensional Fund Advisors opened 49 new positions and exited 103, leaving the 3,516-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2023 buy was Veralto: 961,231 shares worth $79.1M.
- Dimensional Fund Advisors added most to NVIDIA in Q4 2023, an estimated $900M increase.
- Dimensional Fund Advisors's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $430M.
- Dimensional Fund Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $305M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $342B portfolio in Q4 2023.
- Dimensional Fund Advisors opened 49 new positions and closed 103 in Q4 2023.
- Dimensional Fund Advisors's portfolio value rose 12% quarter-over-quarter to $342B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.